Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Budesonide (Primary) ; Budesonide/mesalazine (Primary) ; Mesalazine (Primary)
- Indications Ulcerative proctitis
- Focus Therapeutic Use
- Sponsors Dr Falk Pharma
- 19 Oct 2016 Primary endpoint (Resolution of clinical symptom) has been met,according to the Results presented at the 24th United European Gastroenterology Week.
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week
- 20 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.